Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14
Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,093 | Dovepress* | 2,832+ | 461 | 3,293 | |
PubMed Central* | 261 | 37 | 298 | ||
Totals | 3,093 | 498 | 3,591 | ||
*Since 3 March 2021 |
View citations on PubMed Central and Google Scholar